Sandler, G.; Ilahi, M. A.; Lawson, C. W.
June 1963
Angiology;Jun1963, Vol. 14 Issue 6, p319
Academic Journal
A controlled double-blind study of the use of hydroxychloroquine sulphate, a desludging agent, in the treatment of angina pectoris has been carried out in 18 male patients with well authenticated and typical features of this condition. Response to treatment was assessed by the weekly A controlled double-blind study of the use of hydroxychloroquine sulphate, a desludging agent, in the treatment of angina pectoris has been carried out in 18 male patients with well authenticated and typical features of this condition. Response to treatment was assessed by the weekly consumption of glyceryl trinitrate tablets, and more objectively, by a specially devised exercise tolerance test which allowed the patient to exercise at his own speed and within the limits of his own capacity. There was no significant change in either the frequency of anginal attacks or the performance of exercise while the drug was in use. Similarly there was no significant change in either the subjective or objective evidence of myocardial ischemia with hydroxychloroquine. The side effects of the drug were infrequent and of a minor degree with a dose of 200 mg four times daily. The relationship between sludging of red cells and ischemic heart disease is briefly discussed. From the present study it is concluded that there is no evidence supporting the use of hydroxychloroquine sulphate in angina pectoris. The importance of a controlled study and objective criteria of improvement in the assessment of an antianginal drug is pointed out.


Related Articles

  • Long--Acting Nitroglycerin for Angina, 1982: Old Dog, New Tricks. Reichek, Nathaniel; Sutton, Martin St. John // Annals of Internal Medicine;Nov82, Vol. 97 Issue 5, p774 

    Editorial. Focuses on the use of nitroglycerin in the treatment of angina. Basic action of nitroglycerin; Physiologic effects of nitroglycerin; Hemodynamic consequences of nitroglycerin; Description of the preparations of cutaneous nitroglycerin.

  • Efficacy of Nitroglycerin Patches: Fact or Fancy? Parker, John O. // Annals of Internal Medicine;Apr85, Vol. 102 Issue 4, p548 

    Editorial. Discusses research on the assessment of the efficacy of nitroglycerin patches in the treatment of angina pectoris. Effect of the administration of the patches on a patient's exercise time; Comparison with placebo medication; Issues considered in the administration of nitroglycerin...

  • Ranolazine extended release is a useful adjunct in the treatment of chronic stable angina pectoris.  // Drugs & Therapy Perspectives;Jan2007, Vol. 23 Issue 1, p1 

    Ranolazine extended release (ER) is indicated for the combination treatment of chronic stable angina in patients who have not achieved an adequate response with other antianginals. As add-on therapy with other antianginals, ranolazine ER improves exercise tolerance, reduces the frequency of...

  • Nitroglycerin Sublingual.  // AHFS Consumer Medication Information;Apr2018, p1 

    Nitroglycerin spray and tablets are used to treat episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood vessels that supply blood to the heart). The spray and tablets may also be taken just before activities that may cause episodes of angina in order...

  • ASSESSING THE EFFICACY OF DANSHENFORM COMPOUND IN PATIENTS WITH STABLE ANGINA PECTORIS. Hassan, Mahmood ul; Qureshi, Saqib; Hussain, Chiragh; Gul, Adnan Mahmood; Hafizullah, Mohammad // JPMI: Journal of Postgraduate Medical Institute;2012, Vol. 26 Issue 1, p17 

    Objective: To assess the efficacy of danshenform compound in patient with angina pectoris already on optimal dose of anti anginal therapy assessed by exercise tolerance test. Methodology: Thirty eight patients with stable angina were included in the study. Patients were exercised on treadmill...

  • Drug treatment of chronic stable angina pectoris.  // British Medical Journal;2/25/1978, Vol. 1 Issue 6111, p462 

    Identifies the importance of beta-adrenoceptor-blocking drugs for the management of patients with chronic stable angina pectoris. Reduction of the frequency and severity of anginal attacks; Reduction of glyceryl trinitrate consumption; Ameleoration of electrocardiographic ST segment depression;...

  • EECP.  // Mayo Clinic Health Letter;Oct2001, Vol. 19 Issue 10, p4 

    Focuses on the use of enhanced external counterpulsation (EECP) for the nonsurgical therapy of angina pectoris caused by narrowed or obstructed coronary arteries. Symptoms of chest pain; Steps in EECP therapy; Theories behind the chest pain relief in EECP; Risk factors of chest pain. INSET:...

  • Contemporary Management of Angina: Part II. Medical Management of Chronic Stable Angina. Zanger, Diane R.; Solomon, Allen J. // American Family Physician;1/1/2000, Vol. 61 Issue 1, p129 

    Part II. Provides information on the contemporary medical management of chronic stable angina pectoris. Measures for eliminating risk factors of angina; List of antianginal agents.

  • TO FIGHT BACK AGAINST HEART PROBLEMS... Lally, Steven; Shimer, Porter; London, Cemela; Eickmeier, Jan; Sangiorgio, Maureen; Piszczek, Carole // Prevention;Dec89, Vol. 41 Issue 12, p46 

    Describes remedies to prevent and treat heart problems. Use of salt to ensure faster absorption of nitroglycerin tablets for angina relief; Benefits of a moderate program of aerobic activity to heart attack patients; Use of streptokinase as an anticoagulant.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics